201 related articles for article (PubMed ID: 23918416)
1. Interstitial 12p13.1 deletion involving GRIN2B in three patients with intellectual disability.
Dimassi S; Andrieux J; Labalme A; Lesca G; Cordier MP; Boute O; Neut D; Edery P; Sanlaville D; Schluth-Bolard C
Am J Med Genet A; 2013 Oct; 161A(10):2564-9. PubMed ID: 23918416
[TBL] [Abstract][Full Text] [Related]
2. 3q27.3 microdeletional syndrome: a recognisable clinical entity associating dysmorphic features, marfanoid habitus, intellectual disability and psychosis with mood disorder.
Thevenon J; Callier P; Poquet H; Bache I; Menten B; Malan V; Cavaliere ML; Girod JP; Thauvin-Robinet C; El Chehadeh S; Pinoit JM; Huet F; Verges B; Petit JM; Mosca-Boidron AL; Marle N; Mugneret F; Masurel-Paulet A; Novelli A; Tümer Z; Loeys B; Lyonnet S; Faivre L
J Med Genet; 2014 Jan; 51(1):21-7. PubMed ID: 24133203
[TBL] [Abstract][Full Text] [Related]
3. A new syndrome of intellectual disability with dysmorphism due to TBL1XR1 deletion.
Pons L; Cordier MP; Labalme A; Till M; Louvrier C; Schluth-Bolard C; Lesca G; Edery P; Sanlaville D
Am J Med Genet A; 2015 Jan; 167A(1):164-8. PubMed ID: 25425123
[TBL] [Abstract][Full Text] [Related]
4. GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy.
Lemke JR; Hendrickx R; Geider K; Laube B; Schwake M; Harvey RJ; James VM; Pepler A; Steiner I; Hörtnagel K; Neidhardt J; Ruf S; Wolff M; Bartholdi D; Caraballo R; Platzer K; Suls A; De Jonghe P; Biskup S; Weckhuysen S
Ann Neurol; 2014 Jan; 75(1):147-54. PubMed ID: 24272827
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 12p Deletion Spanning the GRIN2B Gene Presenting With a Neurodevelopmental Phenotype: A Case Report and Review of Literature.
Mishra N; Kouzmitcheva E; Orsino A; Minassian BA
Child Neurol Open; 2016; 3():2329048X16629980. PubMed ID: 28503605
[TBL] [Abstract][Full Text] [Related]
6. Interstitial 1q23.3q24.1 deletion in a patient with renal malformation, congenital heart disease, and mild intellectual disability.
Mackenroth L; Hackmann K; Klink B; Weber JS; Mayer B; Schröck E; Tzschach A
Am J Med Genet A; 2016 Sep; 170(9):2394-9. PubMed ID: 27255444
[TBL] [Abstract][Full Text] [Related]
7. Interstitial deletion of 3p22.3p22.2 encompassing ARPP21 and CLASP2 is a potential pathogenic factor for a syndromic form of intellectual disability: a co-morbidity model with additional copy number variations in a large family.
Marangi G; Orteschi D; Milano V; Mancano G; Zollino M
Am J Med Genet A; 2013 Nov; 161A(11):2890-3. PubMed ID: 24127197
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic characterization and genotype/phenotype analysis in a patient with a de novo 8p23.2p23.3 deletion/12p13.31p13.33 duplication.
Margari L; Di Cosola ML; Buttiglione M; Pansini A; Buonadonna AL; Craig F; Cariola F; Petruzzelli MG; Gentile M
Am J Med Genet A; 2012 Jul; 158A(7):1713-8. PubMed ID: 22639464
[TBL] [Abstract][Full Text] [Related]
9. Phenotype-genotype correlation of a patient with a "balanced" translocation 9;15 and cryptic 9q34 duplication and 15q21q25 deletion.
Papadopoulou E; Sismani C; Christodoulou C; Ioannides M; Kalmanti M; Patsalis P
Am J Med Genet A; 2010 Jun; 152A(6):1515-22. PubMed ID: 20503328
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype relationship in a child with 2.3 Mb de novo interstitial 12p13.33-p13.32 deletion.
Fanizza I; Bertuzzo S; Beri S; Scalera E; Massagli A; Sali ME; Giorda R; Bonaglia MC
Eur J Med Genet; 2014 Jul; 57(7):334-8. PubMed ID: 24780630
[TBL] [Abstract][Full Text] [Related]
11. Microdeletion of 12q24.31: report of a girl with intellectual disability, stereotypies, seizures and facial dysmorphisms.
Palumbo O; Palumbo P; Delvecchio M; Palladino T; Stallone R; Crisetti M; Zelante L; Carella M
Am J Med Genet A; 2015 Feb; 167A(2):438-44. PubMed ID: 25428890
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular findings in 39 patients with KBG syndrome caused by deletion or mutation of ANKRD11.
Goldenberg A; Riccardi F; Tessier A; Pfundt R; Busa T; Cacciagli P; Capri Y; Coutton C; Delahaye-Duriez A; Frebourg T; Gatinois V; Guerrot AM; Genevieve D; Lecoquierre F; Jacquette A; Khau Van Kien P; Leheup B; Marlin S; Verloes A; Michaud V; Nadeau G; Mignot C; Parent P; Rossi M; Toutain A; Schaefer E; Thauvin-Robinet C; Van Maldergem L; Thevenon J; Satre V; Perrin L; Vincent-Delorme C; Sorlin A; Missirian C; Villard L; Mancini J; Saugier-Veber P; Philip N
Am J Med Genet A; 2016 Nov; 170(11):2847-2859. PubMed ID: 27605097
[TBL] [Abstract][Full Text] [Related]
13. Functional Evaluation of a Novel GRIN2B Missense Variant Associated with Epilepsy and Intellectual Disability.
Wang X; Mei D; Gou L; Zhao S; Gao C; Guo J; Luo S; Guo B; Yang Z; Wang Q; Tan T; Zhang Y
Neuroscience; 2023 Aug; 526():107-120. PubMed ID: 37385334
[TBL] [Abstract][Full Text] [Related]
14. 15q26.1 microdeletion encompassing only CHD2 and RGMA in two adults with moderate intellectual disability, epilepsy and truncal obesity.
Courage C; Houge G; Gallati S; Schjelderup J; Rieubland C
Eur J Med Genet; 2014 Sep; 57(9):520-3. PubMed ID: 24932903
[TBL] [Abstract][Full Text] [Related]
15. Refinement of the deletion in 8q22.2-q22.3: the minimum deletion size at 8q22.3 related to intellectual disability and epilepsy.
Kuroda Y; Ohashi I; Saito T; Nagai J; Ida K; Naruto T; Iai M; Kurosawa K
Am J Med Genet A; 2014 Aug; 164A(8):2104-8. PubMed ID: 24801133
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for GRIN2B mutation as the cause of severe epileptic encephalopathy.
Smigiel R; Kostrzewa G; Kosinska J; Pollak A; Stawinski P; Szmida E; Bloch M; Szymanska K; Karpinski P; Sasiadek MM; Ploski R
Am J Med Genet A; 2016 Dec; 170(12):3265-3270. PubMed ID: 27605359
[TBL] [Abstract][Full Text] [Related]
17. Interstitial microdeletion of 17q11.2 is associated with hypotonia, fatigue, intellectual disability, and a subtle facial phenotype in three unrelated patients.
Osio D; Rankin J; Koillinen H; Reynolds A; Van Esch H
Am J Med Genet A; 2018 Jan; 176(1):209-213. PubMed ID: 29130599
[TBL] [Abstract][Full Text] [Related]
18. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.
Endele S; Rosenberger G; Geider K; Popp B; Tamer C; Stefanova I; Milh M; Kortüm F; Fritsch A; Pientka FK; Hellenbroich Y; Kalscheuer VM; Kohlhase J; Moog U; Rappold G; Rauch A; Ropers HH; von Spiczak S; Tönnies H; Villeneuve N; Villard L; Zabel B; Zenker M; Laube B; Reis A; Wieczorek D; Van Maldergem L; Kutsche K
Nat Genet; 2010 Nov; 42(11):1021-6. PubMed ID: 20890276
[TBL] [Abstract][Full Text] [Related]
19. Evidence for effect of l-serine, a novel therapy for GRIN2B-related neurodevelopmental disorder.
den Hollander B; Veenvliet ARJ; Rothuizen-Lindenschot M; van Essen P; Peters G; Santos-Gómez A; Olivella M; Altafaj X; Brands MM; Jacobs BAW; van Karnebeek CD
Mol Genet Metab; 2023 Mar; 138(3):107523. PubMed ID: 36758276
[TBL] [Abstract][Full Text] [Related]
20. Human GRIN2B variants in neurodevelopmental disorders.
Hu C; Chen W; Myers SJ; Yuan H; Traynelis SF
J Pharmacol Sci; 2016 Oct; 132(2):115-121. PubMed ID: 27818011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
